Breaking News

ICON Acquires PriceSpective

Value strategy consultancy deepens pricing and market access capabilities

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

ICON has acquired PriceSpective LLC, a value strategy consultancy. The acquisition strengthens ICON’s expertise in value-based pricing and market access and, in concert with the recently acquired Oxford Outcomes’ health economics and patient reported outcomes services, will create “the industry’s most integrated regulatory, clinical and market access solution,” according to an ICON statement.   PriceSpective is headquartered in Philadelphia, with offices in London, Los Angeles,...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters